Similar Posts
What’s a Patient to Think? Prescription for Confusion – NY Times Editorial
What’s a Patient to Think? Prescription for Confusion – NY Times Editorial Tue, 28 Dec 2004 At long last, The New York Times has validated the well-placed anger and frustration that patients feel at having their trust in medicine and the nation’s oversight agents betrayed: “Now I just don’t trust…
Natrecor found to worsen kidney function, hasten death – NYT
Natrecor found to worsen kidney function, hasten death – NYT Tue, 17 May 2005 Natrecor, a drug approved by the FDA for treating patients with heart failure, is being widely prescribed off label for unapproved uses. The drug is prescribed for so-called “tune-ups” in outpatient clinics – although that use…
$1.1 Billion in Stimulus Package for Comparing Medical Treatments
This has the potential for restoring integrity to medicine by providing doctors and the public with impartial risk / benefit information about existing treatments devoid of commercial bias.
Medicare Will cover New Treatments But Patients Will be Required to Enroll in Clinical Trials
Medicare Will cover New Treatments But Patients Will be Required to Enroll in Clinical Trials Fri, 5 Nov 2004 Dr. Mark McClellan, Director of Medicare, estimates that of Medicare’s $320 billion budget, “a third of all medical expenditures are for unnecessary or ill-advised treatments.” Medicare’s chief medical officer, Dr. Sean…
References: Impact of FDA inclusion of children as test subjects
References for THE IMPACT OF THE FDA MODERNIZATION ACT ON THE RECRUITMENT OF CHILDREN FOR RESEARCH Vera Hassner Sharav Published in ETHICAL HUMAN SCIENCES & SERVICES Summer 2003, vol. 5 pp. 83-108 Agency for Health Care Research & Quality. (1999). Treatment of attention-deficit/hyperactivity disorder: Summary, evidence Report / Technology assessment…
Drug Companies are Outsourcing Drug Trials – WP
Drug Companies are Outsourcing Drug Trials – WP Wed, 4 May 2005 The Washington Post reports that a study by Tufts has found a drop in the number of pharmaceutical company sponsored drug trials. Fewer new drug applications are being submitted to the FDA, and there has been a drop…

